 | Up a level |
Yoosefee, S. and Ananloo, E.S. and Joghataei, M.-T. and Karimipour, M. and Hadjighassem, M. and Mohaghghegh, H. and Tehrani-Doost, M. and Rahimi, A.-A. and Abdolmaleky, H.M. and Hatami, M. (2016) Association between neuregulin-1 gene variant (rs2439272) and schizophrenia and its negative symptoms in an Iranian population. Iranian Journal of Psychiatry, 11 (3). pp. 147-153.
Nohesara, S. and Ghadirivasfi, M. and Barati, M. and Ghasemzadeh, M.-R. and Narimani, S. and Mousavi-Behbahani, Z. and Joghataei, M. and Soleimani, M. and Taban, M. and Mehrabi, S. and Thiagalingam, S. and Abdolmaleky, H.M. (2016) Methamphetamine-induced psychosis is associated with DNA hypomethylation and increased expression of AKT1 and key dopaminergic genes. American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics, 171 (8). pp. 1180-1189.
Abdolmaleky, H.M. and Pajouhanfar, S. and Faghankhani, M. and Joghataei, M.T. and Mostafavi, A. and Thiagalingam, S. (2015) Antipsychotic drugs attenuate aberrant DNA methylation of DTNBP1 (dysbindin) promoter in saliva and post-mortem brain of patients with schizophrenia and Psychotic bipolar disorder. American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics, 168 (8). pp. 687-696.
Abdolmaleky, H.M. and Thiagalingam, S. (2011) Can the schizophrenia epigenome provide clues for the molecular basis of pathogenesis? Epigenomics, 3 (6). pp. 679-683.
Abdolmaleky, H.M. and Yaqubi, S. and Papageorgis, P. and Lambert, A.W. and Ozturk, S. and Sivaraman, V. and Thiagalingam, S. (2011) Epigenetic dysregulation of HTR2A in the brain of patients with schizophrenia and bipolar disorder. Schizophrenia Research, 129 (2-3). pp. 183-190.
Abdolmaleky, H.M. (2011) The prospects of epigenetics in neuroscience. Basic and Clinical Neuroscience, 2 (2). pp. 3-5.
Abdolmaleky, H.M. and Ahmadkhaniha, H.R. and Nohesara, S. and Smith, C.L. (2008) Epigenetic and genetic aberrations of the brain dopaminergic system in schizophrenia and bipolar disorder: Achievements and prospective. Iranian Journal of Psychiatry and Behavioral Sciences, 2 (1). pp. 4-13.
Abdolmaleky, H.M. and Zhou, J.-R. and Thiagalingam, S. and Smith, C.L. (2008) Epigenetic and pharmacoepigenomic studies of major psychoses and potentials for therapeutics. Pharmacogenomics, 9 (12). pp. 1809-1823.
Abdolmaleky, H.M. and Cheng, K.-H. and Faraone, S.V. and Wilcox, M. and Glatt, S.J. and Gao, F. and Smith, C.L. and Shafa, R. and Aeali, B. and Carnevale, J. and Pan, H. and Papageorgis, P. and Ponte, J.F. and Sivaraman, V. and Tsuang, M.T. and Thiagalingam, S. (2006) Hypomethylation of MB-COMT promoter is a major risk factor for schizophrenia and bipolar disorder. Human Molecular Genetics, 15 (21). pp. 3132-3145.
Abdolmaleky, H.M. and Thiagalingam, S. and Wilcox, M. (2005) Genetics and epigenetics in major psychiatric disorders: Dilemmas, achievements, applications, and future scope. American Journal of PharmacoGenomics, 5 (3). pp. 149-160.
Abdolmaleky, H.M. and Cheng, K.-H. and Russo, A. and Smith, C.L. and Faraone, S.V. and Wilcox, M. and Shafa, R. and Glatt, S.J. and Nguyen, G. and Ponte, J.F. and Thiagalingam, S. and Tsuang, M.T. (2005) Hypermethylation of the reelin (RELN) promoter in the brain of schizophrenic patients: A preliminary report. American Journal of Medical Genetics - Neuropsychiatric Genetics, 134 B (1). pp. 60-66.
